International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

  1. Dombret, H.
  2. Seymour, J.F.
  3. Butrym, A.
  4. Wierzbowska, A.
  5. Selleslag, D.
  6. Jang, J.H.
  7. Kumar, R.
  8. Cavenagh, J.
  9. Schuh, A.C.
  10. Candoni, A.
  11. Récher, C.
  12. Sandhu, I.
  13. Del Castillo, T.B.
  14. Al-Ali, H.K.
  15. Martinelli, G.
  16. Falantes, J.
  17. Noppeney, R.
  18. Stone, R.M.
  19. Minden, M.D.
  20. McIntyre, H.
  21. Songer, S.
  22. Lucy, L.M.
  23. Beach, C.L.
  24. Döhner, H.
Aldizkaria:
Blood

ISSN: 1528-0020,  0006-4971

Argitalpen urtea: 2015

Alea: 126

Zenbakia: 3

Orrialdeak: 291-299

Mota: Artikulua

DOI: 10.1182/BLOOD-2015-01-621664 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus